The Kier and Babcock share prices are rising. Should I buy?

It’s been a roller-coaster few years for outsourcers Kier and Babcock, but with their share prices on the up, could it be time to buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Kier (LSE: KIE) and Babcock (LSE: BAB) share prices have stormed up from their 2021 lows. Nevertheless, they remain far below their pre-pandemic levels.

Could these outsourcers be in the foothills of a big recovery? And should I buy shares in them today?

When Kier and Babcock shares were overpriced

I turned bearish on the outsourcing sector in 2016/17. Having analysed a number of companies’ accounts, I concluded that with debt and worrying signs of aggressive accounting, their balance sheets were likely a lot more fragile than they appeared on the surface.

A few other analysts had reached the same conclusion. But more were to follow. Disclosable short positions in outsourcers began to rise steeply. Hedge funds were increasingly betting that Kier and Babcock shares (among others) were overpriced and set to collapse. At peak, almost 9% of Babcock’s shares and 14% of Kier’s were being shorted.

Aggressive accounting and weak balance sheets were ultimately exposed. However, much has changed at the two firms. These changes are why I’m considering whether to buy the stocks today.

Boardroom clear-outs and accounting clean-ups

Kier and Babcock have new management teams and I think these changes bode well for their share prices. The clear-outs of the old executives alone wouldn’t be sufficient for me to consider investing. But there have been other important changes.

Both companies have taken steps to improve what were previously opaque financial statements. Kier has implemented recommendations, on things like revenue recognition, made following an enquiry by the Financial Reporting Council’s Corporate Reporting Review Team. Management has also made other changes. These include the presentation of non-statutory profit “to improve the transparency and clarity of the group’s financial performance.”

At Babcock, new management has conducted a “contract profitability and balance sheet review.” This has identified impairments and charges totalling around £1.7bn. The company’s preliminary results for its financial year ended 31 March are currently delayed. This is in part because of “the large number of potential adjustments under consideration.”

Would I buy Kier at the current share price?

In addition to the management changes and accounting clean-up, Kier has substantially strengthened its balance sheet recently. It has raised £241m of new equity and sold its house-building business for £110m. The CEO has said this represents “the final milestone” in reshaping the group.

Kier trades at 4.6 times forecast earnings at a current share price of 129p. I think the stock looks very buyable on this valuation. However, I do have to accept the risk the shares may not perform well, if ‘new’ Kier’s strategy falters and it fails to meet its medium-term financial targets.

Would I buy Babcock at the current share price?

“We aim to return Babcock to strength without the need for an equity issue,” the company’s CEO has said. This will depend on the success of its self-help measures. These seem to include disposing of assets of at least £400m by next April.

Babcock is rated at 8.9 times forecast earnings at a current share price of 295p. This enough to put the stock on my watchlist. I await further details on the company’s financials and plans when those delayed preliminary results are published

Finally, its perhaps worth noting there are no longer any disclosable short positions in Kier and only one (0.59% of the shares) in Babcock.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A pastel colored growing graph with rising rocket.
Investing Articles

How much passive income could I make for every £1,000 invested in Aviva shares?

Even a relatively small investment in Aviva shares could generate much greater passive income, particularly if the dividends are reinvested…

Read more »

Close-up of British bank notes
Investing Articles

I’m considering 100 shares in this FTSE 250 gem to aim for £300 a month in dividends

Mark Hartley outlines why a lesser-known banking stock from the FTSE 250's worth considering for an income portfolio in 2024.

Read more »

Investing Articles

History suggests these UK shares might soar if interest rates are cut in August

Some UK shares could rocket if interest rates fall from its 5.25% high next month. And there's one our writer…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

Here’s why H1 results could boost the AstraZeneca share price

The AstraZeneca share price has been a success story in the past five years. With H1 results due, can it…

Read more »

Investing Articles

£17,365 in savings? Here’s how I’d use it to target a £6,700-a-month passive income

Here's how a lump sum investment could pave the way for me to make a four-figure monthly passive income in…

Read more »

Investing Articles

Down more than 10% in 6 months, Fools are backing these 5 UK stocks to reverse that – and then some! – by 2025

Some of our UK free-site writers have put forward their candidates for turnaround stocks!

Read more »

Investing Articles

Down 23%! Should I buy more CrowdStrike shares for my Stocks and Shares ISA?

Sometimes bad news can be good news for long-term investors. But is that the case for CrowdStrike in relation to…

Read more »

Investing Articles

2 UK shares near 52-week lows I’m considering snapping up

These UK shares are loitering near, or at, 52-week lows. Are these prime opportunities for our writer to boost her…

Read more »